'Leadership through innovation'   Amersham logo
Leadership through innovation The Report
'Bringing important benefits to patients' Visipaque - excellent choice for high-risk patients
MabSelect - a customer-driven innovation for monoclonal antibody drugs IN Cell Analyzer - changing the landscape of cancer research
To learn more about some of our innovative products please select from the picture links above.
In our 2002 Annual Report we explained our business model, and how the three parts of our business are working more closely together to change the way medicine will be delivered in the future.
Highlights from the first half
Business highlights at a glance
Report of the Chairman and the Chief Executive
Dividend calendar
Search this site: